Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
54.5%
% of SYNB's 35 holdings also in WDNA
21.4%
% of WDNA's 90 holdings also in SYNB
Overlap by Weight
Sector Drift (SYNB minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SYNB |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 4.0% | 2.7% | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 1.5% | 1.8% | 1.5% |
|
DUPONT DE NEMOURS INC | 3.5% | 1.5% | 1.5% |
|
TWIST BIOSCIENCE CORP. | 1.4% | 3.3% | 1.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.2% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
SYNB Overweight Relative to WDNA
|
ABBVIE INC | 5.5% |
|
THERMO FISHER SCIENTIFIC INC | 5.4% |
 |
NOVOZYMES A/S-UNSPONS ADR | 4.6% |
|
DANAHER CORP | 4.2% |
|
ASCENDIS PHARMA A/S | 4.0% |
|
ALPHABET INC. CLASS A | 3.9% |
|
BIO-RAD LABORATORIES-CL A | 3.8% |
|
NVIDIA CORP | 3.5% |
|
CORTEVA INC | 3.5% |
|
ASTRAZENECA PLC-SPONS ADR | 2.9% |
SYNB Underweight Relative to WDNA
|
NATERA INC | -3.7% |
|
NOVOZYMES A/S-B SHARES | -2.9% |
|
VERICEL CORPORATION | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
VERACYTE INC | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
GILEAD SCIENCES INC | -1.9% |
|
TWIST BIOSCIENCE CORP. | -1.9% |
|
UNITED THERAPEUTICS CORP | -1.7% |